Laurent Eckert

Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

TRP Channels as Potential Drug Targets

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder

Depression

Improving the Prediction of Treatment Response in Depression:Integration of Clinical, Cognitive, Psychophysiological, Neuroimaging, and Genetic Measures

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model

Asthma

Graphical Tools for Network Meta-Analysis in STATA

The JAK/STAT signaling pathway: from bench to clinic

New and Anticipated Therapies for Severe Asthma

A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Indirect Comparisons: A Review of Reporting and Methodological Quality

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

EPOS2020: A Major Step Forward

Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20)

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges

Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx

Biological Therapies for Atopic Dermatitis: A Systematic Review

The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Immunological and hematological effects of IL‐5(Rα)‐targeted therapy: An overview

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Worldwide Epidemiology of Atrial Fibrillation

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Cutaneous manifestations in COVID‐19: a first perspective

A review of depression and suicide risk assessment using speech analysis

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation

Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons

Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey

Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults

Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Epidemiology of atopic dermatitis in adults: Results from an international survey

Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults